Abstract
A single, minute dose of tetanus toxin injected into mammalian cerebral cortex induces a chronic epileptic syndrome. Seizures lasting up to 3 minutes occur spontaneously and intermittently for several weeks to months. The cellular mechanisms of this model have been studied in detail using brain slicesin vitro. Initially the release of the inhibitory neurotransmitter, GABA, is blocked, but after 2–4 weeks, other mechanisms take over. Intrahippocampal tetanus toxin models human complex partial seizures (temporal lobe epilepsy). It results in consistent behavioural changes analogous with those seen clinically, in spite of the limited neuronal loss found in only 10–30% of rats. Treatment with carbamazepine ameliorates both the seizures and their behavioural consequences. Tetanus toxin provides a versatile and long-lasting model of focal epilepsies.
Sommario
La singola iniezione di una dose minima di tossina tetanica nella corteccia cerebrale dei mammiferi induce una sindrome epilettica cronica. Le crisi di durata fino a 3 minuti si manifestano spontaneamente in modo intermittente per parecchie settimane o mesi. I meccanismi cellulari di questo modello sono stati studiati in dettaglio in sezioni di tessuto cerebrale incubatein vitro. Inizialmente il rilascio del neurotrasmettitore inibitorio, GABA, è bloccato ma dopo 2–4 settimane subentrano attivi meccanismi. L'iniezione intraippocampale di tossina tetanica riproduce le crisi parziali complesse che si osservano nelle epilessie del lobo temporale. Essa determina modificazioni comportamentali analoghe a quelle osservate in clinica, malgrado il limitato danno neuronale, presente solo nel 10–30% dei ratti. Il trattamento con carbamazepina ha un effetto favorevole sia sulle crisi che sulle loro conseguenze comportamentali. La tossina tetanica permette di ottenere un modello versatile e persistente di epilessie focali.
Similar content being viewed by others
References
Bagetta G., Corasaniti M.T., Nisticó G., Bowery N.G.:Behavioural and neuropathological effects produced by tetanus toxin injected into the hippocampus of rats. Neuropharmacol. 29:765–770 1990.
Brace H.M., Jefferys J.G.R., Mellanby J.:Long-term changes in hippocampal physiology and in learning ability of rats after intrahippocampal tetanus toxin. J. Physiol. (Lond.) 368:343–357, 1985.
Brener K., Chagnac-Amitai Y., Jefferys J.G.R., Gutnick M.J.:Chronic epileptic foci in neocortex: in vivo and in vitro effects of tetanus toxin. Eur. J. Neurosci. 3:47–54, 1991.
Chagnac-Amitai Y., Connors B.W.:Horizontal spread of synchronized activity in neocortex and its control by GABA-mediated inhibition. J. Neurophysiol. 61:747–758, 1989.
Darcey T.M., Williamson P.D.:Chronic/semichronic limbic epilepsy produced by microinjection of tetanus toxin in cat hippocampus. Epilepsia 33:402–419, 1992.
Empson R.M., Amitay Y., Jefferys J.G.R., Gutnick M.J.:Injection of tetanus toxin into the neocortex elicits persistent epileptiform activity but only transient impairment of GABA release. Neurosci. 57:235–239, 1993.
Empson R.M., Jefferys J.G.R.:Inhibitory synaptic function in primary and secondary chronic epileptic foci induced by intrahippocampal tetanus toxin in the rat. J. Physiol. (Lond.) 465:595–614, 1993.
Finnerty G.T., Jefferys J.G.R.:Spontaneous epileptiform activity in freely moving rats with epileptic foci induced by tetanus toxin. J. Physiol. (Lond.) 467:319P, 1993.
Hawkins C.A.:Studies on an animal model of temporal lobe epilepsy. D. Phil. thesis: Oxford University, 1985.
Hawkins C.A., Mellanby J., Brown J.:Antiepileptic and antiamnesic effect of carbamazepine in experimental limbic epilepsy. J. Neurol. Neurosurg. Psychiatry 48:459–468, 1985.
Hawkins C.A., Mellanby J.H.:Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsy. Acta Neurol. Scand. 74 (suppl. 109): 117–121, 1986.
Hawkins C.A., Mellanby J.H.:Limbic epilepsy induced by tetanus toxin: a longitudinal electroencephalographic study. Epilepsia 28:431–444, 1987.
Jefferys J.G.R.:Chronic epileptic foci in vitro in hippocampal slices from rats with the tetanus toxin epileptic syndrome. J. Neurophysiol. 62:458–468, 1989.
Jefferys J.G.R., Empson R.M.:Development of chronic secondary epileptic foci following intrahippocampal injection of tetanus toxin. Exp. Physiol. 75:733–736, 1990.
Jefferys J.G.R., Evans B.J., Hughes S.A., Williams S.F.:Neuropathology of the chronic epileptic syndrome induced by intrahippocampal tetanus toxin in the rat: preservation of pyramidal cells and incidence of dark cells. Neuropathol. Appl. Neurobiol. 18:53–70, 1992.
Jefferys J.G.R., Williams S.F.:Physiological and behavioural consequences of seizures induced in the rat by intrahippocampal tetanus toxin. Brain 110:517–532, 1987.
Lee C., Hrachovy R., Smith K., Frost J.J., Swann J.:Seizures produced in neonatal rats by stereotaxic injection of tetanus toxin (TT): in vivo and in vitro models of seizures in early infancy. Soc. Neurosci. Abstr. 19:1870, 1993.
Louis E.D., Williamson P.D., Darcey T.M.:Chronic focal epilepsy induced by microinjection of tetanus toxin into the cat motor cortex. Electroencephalogr. Clin. Neurophysiol. 75:548–557, 1990.
Mellanby J.:Tetanus toxin as a tool for investigating the consequences of excessive neuronal excitation. In: Dasgupta, B.R. (ed.)Botulinum and tetanus neurotoxins, Plenum Press: New York, pp. 291–297, 1993.
Mellanby J., George G., Robinson A., Thompson P.:Epileptiform syndrome in rats produced by injecting tetanus toxin into the hippocampus. J. Neurol. Neurosurg. Psychiatry 40:404–414, 1977.
Mellanby J., Green J.:How does tetanus toxin act?. Neurosci. 6:281–300, 1981.
Mellanby J., Hawkins C., Mellanby H., Rawlins J.N.P., Impey M.E.:Tetanus toxin as a tool for studying epilepsy. J. Physiol. (Paris) 79:207–215, 1984.
Mellanby J., Strawbridge P., Collingridge G.I., George G., Rands G., Stroud C., Thompson:Behavioural correlates of an experimental hippocampal epileptiform syndrome in rats. J. Neurol. Neurosurg. Psychiatry 44:1084–1093, 1981.
Najlerahim A., Williams S.F., Pearson R.C.A., Jefferys J.G.R.:Increased expression of GAD mRNA during the chronic epileptic syndrome due to intrahippocampal tetanus toxin. Exp. Brain Res. 90:332–342, 1992.
Nicholls B., Shaw A., Mellanby J.H.:Effect of the NMDA receptor antagonist, D-2-amino-5-phosphonovaleric acid (D-APV) on tetanus toxin induced epileptiform syndrome. Neurosci. Lett. Suppl. 36:S25; 1989.
Roux E., Borrell A.:Tétanos cérébral et immunité contre le tétanos. Ann. Inst. Pasteur 4:225–239, 1898.
Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., Dasgupta B.R., Montecucco C.:Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832–835, 1992.
Shaw J.A.G., Perry V.H., Mellanby J.:Tetanus toxin-induced seizures cause microglial activation in rat hippocampus. Neurosci. Lett. 120:66–69, 1990.
Shaw J.A.G., Perry V.H., Mellanby J.:MHC class II expression by microglia in tetanus toxininduced experimental epilepsy in the rat. Neuropathol. Appl. Neurobiol. 20:392–398, 1994.
Whittington M.A., Jefferys J.G.R.:Epileptic activity outlasts disinhibition after intrahippocampal tetanus toxin in the rat. J. Physiol. (Lond.) 481:593–604, 1994.
Author information
Authors and Affiliations
Additional information
The authors' work is supported by the Wellcome Trust, Ciba Geigy, the British Epilepsy Research Foundation and St. Hilda's College.
Rights and permissions
About this article
Cite this article
Jefferys, J.G.R., Borck, C. & Mellanby, J. Chronic focal epilepsy induced by intracerebral tetanus toxin. Ital J Neuro Sci 16, 27–32 (1995). https://doi.org/10.1007/BF02229071
Issue Date:
DOI: https://doi.org/10.1007/BF02229071